BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25496409)

  • 1. Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
    Tanaka M; Koike R; Sakai R; Saito K; Hirata S; Nagasawa H; Kameda H; Hara M; Kawaguchi Y; Tohma S; Takasaki Y; Dohi M; Nishioka Y; Yasuda S; Miyazaki Y; Kaneko Y; Nanki T; Watanabe K; Yamazaki H; Miyasaka N; Harigai M
    Mod Rheumatol; 2015 Jul; 25(4):609-14. PubMed ID: 25496409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
    Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
    Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.
    Toyoda Y; Hanibuchi M; Kishi J; Kawano H; Morizumi S; Sato S; Kondo M; Takikura T; Tezuka T; Goto H; Nishioka Y
    J Med Invest; 2016; 63(3-4):294-9. PubMed ID: 27644575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease.
    Sun D; Wang Y; Liu Q; Wang T; Li P; Jiang T; Dai L; Jia L; Zhao W; Cheng Z
    Respir Res; 2022 Jan; 23(1):4. PubMed ID: 34996461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis.
    Su R; Bennett M; Jacobs S; Hunter T; Bailey C; Krishnan E; Rosen G; Chung L
    J Rheumatol; 2011 Apr; 38(4):693-701. PubMed ID: 21285162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
    Mittoo S; Jacob T; Craig A; Bshouty Z
    Can Respir J; 2010; 17(6):282-6. PubMed ID: 21165350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study.
    Yamazaki H; Sakai R; Koike R; Miyazaki Y; Tanaka M; Nanki T; Watanabe K; Yasuda S; Kurita T; Kaneko Y; Tanaka Y; Nishioka Y; Takasaki Y; Nagasaka K; Nagasawa H; Tohma S; Dohi M; Sugihara T; Sugiyama H; Kawaguchi Y; Inase N; Ochi S; Hagiyama H; Kohsaka H; Miyasaka N; Harigai M;
    J Rheumatol; 2015 Apr; 42(4):614-22. PubMed ID: 25641893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.
    Chartrand S; Swigris JJ; Peykova L; Fischer A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):296-304. PubMed ID: 26847096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
    Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
    Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia in patients with connective tissue disease.
    Li J; Huang XM; Fang WG; Zeng XJ
    J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
    Zhang Y; Zheng Y
    Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus.
    Yamano Y; Taniguchi H; Kondoh Y; Ando M; Kataoka K; Furukawa T; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    Respirology; 2018 Nov; 23(11):1041-1048. PubMed ID: 30011421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
    Vij R; Strek ME
    Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis.
    Tansey D; Wells AU; Colby TV; Ip S; Nikolakoupolou A; du Bois RM; Hansell DM; Nicholson AG
    Histopathology; 2004 Jun; 44(6):585-96. PubMed ID: 15186274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.